Skip to main content
. Author manuscript; available in PMC: 2016 Jul 18.
Published in final edited form as: Lancet. 2015 May 11;386(9990):258–265. doi: 10.1016/S0140-6736(14)61704-9

Figure 2.

Figure 2

Evidence networks for serious infection among populations. The width of the lines is proportional to the number of randomized controlled trials comparing each pair of treatments, and the size of each treatment node is proportional to the number of randomized participants (sample size).

DMARD= disease-modifying anti-rheumatic drugs; MTX=methotrexate; RCT= randomized controlled trial